U.S. Bankruptcy Judge Robert Drain said allowing the legal shield to
expire at the end of Tuesday would be "quite foolish," given the
mediator's report of a possible deal.
Purdue, maker of the highly addictive OxyContin opioid painkiller,
filed for bankruptcy in 2019 in the face of thousands of lawsuits
accusing it and the Sacklers of fueling an American opioid epidemic
through deceptive marketing.
The opioid abuse crisis has led to nearly 500,000 overdose deaths
over two decades, according to U.S. data.
Members of the Sackler family have denied the allegations.
Purdue’s bankruptcy judge has paused litigation against members of
the Sackler family since 2019, seeking to buy time for the company
to pursue a reorganization in bankruptcy court.
On Monday, the mediator reported that the Sacklers were nearing an
agreement to boost their more than $4.3 billion cash contribution to
resolve the litigation after negotiating with states that objected
to the original terms.
Judge Drain said on Tuesday that "all bets were open" as to whether
the Sacklers would continue to receive legal protection from opioid
lawsuits if the current round of mediation does not result in a new
deal.
[to top of second column] |
If the Sacklers’ legal
protection were allowed to expire, the family
and Purdue would be swept up in a "a firestorm
of uncoordinated litigation" that would destroy
any value the company has left, Purdue attorney
Marshall Huebner told the judge on Tuesday.
Legal protections for the Sacklers have been a point of controversy
throughout Purdue’s bankruptcy.
The current round of mediation began in January, after a U.S.
district judge ruled that Purdue’s bankruptcy reorganization plan
improperly shielded Sackler family members, who had not filed for
Chapter 11 themselves, from opioid litigation.
Attorney Joe Rice, who represents plaintiffs who have sued Purdue
and the Sackler family, said in court on Tuesday that the legal
protections should be allowed to expire.
Allowing lawsuits to proceed could break a holding pattern that
"only benefits the Sackler family," Rice said.
(Reporting by Tom Hals in Wilmington, Delaware and Dietrich Knauth
in New York; editing by Jonathan Oatis, Noeleen Walder and Bill
Berkrot)
[© 2022 Thomson Reuters. All rights
reserved.] This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |